Intelligence · Clinical Development
Pipeline search results
Programs matching “bgb-” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "bgb-" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BGB-58067
BEONE MEDICINES AUS PTY LTD
Glioblastoma (GBM)
1 trial -
BGB-58067
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-A3055
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-A317-A3055-101
BeiGene
Advanced or metastatic solid tumors
1 trial -
BGB-B2033
BEONE MEDICINES AUS PTY LTD
Metastatic Hepatocellular Carcinoma
1 trial -
BGB-B2033-101
BEONE MEDICINES AUS PTY LTD
Selected Advanced or Metastatic Solid Tumors
1 trial -
BGB-B3227
BEONE MEDICINES AUS PTY LTD
Advanced Cancer
1 trial -
BGB-B455
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-C354
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-R046
BEONE MEDICINES AUS PTY LTD
Solid Tumor
1 trial -
Study of BGB-11417 in Patients with Mature B Cell Malignancies
BEONE MEDICINES AUS PTY LTD
Mature B Cell Malignancies
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.